RESEARCHER PROFILE: Compassion and Curiosity
William Kim, M.D., is motivated by two things: compassion and curiosity. Dr. Kim has taken these dual motivations and created a career in which he cares directly for patients and spearheads research that may lead to improved treatment options.
Steps Towards Precision Medicine: Utilizing FFPE Specimens for Comprehensive Genomic Characterization
Roy W. Tarnuzzer, Ph.D., the Biospecimen Core Resource Program Manager at the TCGA Program Office, provides an overview of the Formalin-fixed Paraffin Pilot Project, an initiative to investigate best practices for use of FFPE specimens in genomic studies.
TCGA and Its Vital Role in Understanding How Germline Variation Informs the Landscape of Somatic Alterations in Cancer
Dr. Stephen Chanock, M.D., Director of the Division of Cancer Epidemiology & Genetics at the NCI, discusses how TCGA provides a strong foundation for understanding key biological alterations in cancer.
- September 2015
DNA Methylation Inhibitor Triggers Anti-Viral Immune Response in Cancer
- April 2015
Using TCGA Data to Find a Novel Target for Triple-Negative Breast Cancer
- December 2014
TCGA’s Pan-Cancer Analysis Shows New Possibilities for Classifying Tumors
- June 2014
MTOR Gene Unlocks Two Approaches to Targeted Therapies
- October 2013
Scientists Using TCGA Data Identify 21 Mutational Signatures in Cancer